These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38126958)

  • 1. Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study.
    Sanyal AJ; Loomba R; Anstee QM; Ratziu V; Kowdley KV; Rinella ME; Harrison SA; Resnick MB; Capozza T; Sawhney S; Shelat N; Younossi ZM
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38126958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems.
    Leung HH; Puspanathan P; Chan AW; Nik Mustapha NR; Wong VW; Chan WK
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1131-1138. PubMed ID: 35362158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.
    Brunt EM; Clouston AD; Goodman Z; Guy C; Kleiner DE; Lackner C; Tiniakos DG; Wee A; Yeh M; Leow WQ; Chng E; Ren Y; Boon Bee GG; Powell EE; Rinella M; Sanyal AJ; Neuschwander-Tetri B; Younossi Z; Charlton M; Ratziu V; Harrison SA; Tai D; Anstee QM
    J Hepatol; 2022 May; 76(5):1030-1041. PubMed ID: 35090960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
    Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.
    Sanyal AJ; Ratziu V; Loomba R; Anstee QM; Kowdley KV; Rinella ME; Sheikh MY; Trotter JF; Knapple W; Lawitz EJ; Abdelmalek MF; Newsome PN; Boursier J; Mathurin P; Dufour JF; Berrey MM; Shiff SJ; Sawhney S; Capozza T; Leyva R; Harrison SA; Younossi ZM
    J Hepatol; 2023 Nov; 79(5):1110-1120. PubMed ID: 37517454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.
    Juluri R; Vuppalanchi R; Olson J; Unalp A; Van Natta ML; Cummings OW; Tonascia J; Chalasani N
    J Clin Gastroenterol; 2011 Jan; 45(1):55-8. PubMed ID: 20505526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.
    Davison BA; Harrison SA; Cotter G; Alkhouri N; Sanyal A; Edwards C; Colca JR; Iwashita J; Koch GG; Dittrich HC
    J Hepatol; 2020 Dec; 73(6):1322-1332. PubMed ID: 32610115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.
    Liu F; Goh GB; Tiniakos D; Wee A; Leow WQ; Zhao JM; Rao HY; Wang XX; Wang Q; Wan WK; Lim KH; Romero-Gomez M; Petta S; Bugianesi E; Tan CK; Harrison SA; Anstee QM; Chang PJ; Wei L
    Hepatology; 2020 Jun; 71(6):1953-1966. PubMed ID: 31600834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score.
    Pai RK; Jairath V; Hogan M; Zou G; Adeyi OA; Anstee QM; Aqel BA; Behling C; Carey EJ; Clouston AD; Corey K; Feagan BG; Kleiner DE; Ma C; McFarlane SC; Noureddin M; Ratziu V; Valasek MA; Younossi ZM; Harrison SA; Loomba R
    Hepatology; 2022 Oct; 76(4):1150-1163. PubMed ID: 35332569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.
    Kim HP; Idowu MO; Mospan AR; Allmon AG; Roden M; Newsome P; Lok AS; Thuluvath PJ; Taunk J; Fried MW; Sanyal AJ; Barritt AS;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1472-1480. PubMed ID: 34694013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy.
    Lee K; Jung ES; Yu E; Kang YK; Cho MY; Kim JM; Moon WS; Jeong JS; Park CK; Park JB; Kang DY; Sohn JH; Jin SY
    J Pathol Transl Med; 2020 May; 54(3):228-236. PubMed ID: 32460476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Kleiner DE; Brunt EM; Van Natta M; Behling C; Contos MJ; Cummings OW; Ferrell LD; Liu YC; Torbenson MS; Unalp-Arida A; Yeh M; McCullough AJ; Sanyal AJ;
    Hepatology; 2005 Jun; 41(6):1313-21. PubMed ID: 15915461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies.
    Heinemann F; Gross P; Zeveleva S; Qian HS; Hill J; Höfer A; Jonigk D; Diehl AM; Abdelmalek M; Lenter MC; Pullen SS; Guarnieri P; Stierstorfer B
    Sci Rep; 2022 Nov; 12(1):19236. PubMed ID: 36357500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
    Bastati N; Perkonigg M; Sobotka D; Poetter-Lang S; Fragner R; Beer A; Messner A; Watzenboeck M; Pochepnia S; Kittinger J; Herold A; Kristic A; Hodge JC; Traussnig S; Trauner M; Ba-Ssalamah A; Langs G
    Eur Radiol; 2023 Nov; 33(11):7729-7743. PubMed ID: 37358613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials.
    Iyer JS; Pokkalla H; Biddle-Snead C; Carrasco-Zevallos O; Lin M; Shanis Z; Le Q; Juyal D; Pouryahya M; Pedawi A; Hoffman S; Elliott H; Leidal K; Myers RP; Chung C; Billin AN; Watkins TR; Resnick M; Wack K; Glickman J; Burt AD; Loomba R; Sanyal AJ; Montalto MC; Beck AH; Taylor-Weiner A; Wapinski I
    medRxiv; 2023 Apr; ():. PubMed ID: 37162870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.
    Manning P; Murphy P; Wang K; Hooker J; Wolfson T; Middleton MS; Newton KP; Behling C; Awai HI; Durelle J; Paiz MN; Angeles JE; De La Pena D; McCutchan JA; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2017 Oct; 46(4):1149-1158. PubMed ID: 28225568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance.
    Gill RM; Allende D; Belt PH; Behling CA; Cummings OW; Guy CD; Carpenter D; Neuschwander-Tetri BA; Sanyal AJ; Tonascia J; Van Natta ML; Wilson LA; Yamada G; Yeh M; Kleiner DE;
    Hepatol Commun; 2023 Feb; 7(2):e0033. PubMed ID: 36724127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions.
    Ratziu V; Hompesch M; Petitjean M; Serdjebi C; Iyer JS; Parwani AV; Tai D; Bugianesi E; Cusi K; Friedman SL; Lawitz E; Romero-Gómez M; Schuppan D; Loomba R; Paradis V; Behling C; Sanyal AJ
    J Hepatol; 2024 Feb; 80(2):335-351. PubMed ID: 37879461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.